121 related articles for article (PubMed ID: 34270986)
1. Inhibition of c-Myc using 10058-F4 induces anti-tumor effects in ovarian cancer cells via regulation of FOXO target genes.
Ghaffarnia R; Nasrollahzadeh A; Bashash D; Nasrollahzadeh N; Mousavi SA; Ghaffari SH
Eur J Pharmacol; 2021 Oct; 908():174345. PubMed ID: 34270986
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells.
Wang J; Ma X; Jones HM; Chan LL; Song F; Zhang W; Bae-Jump VL; Zhou C
J Transl Med; 2014 Aug; 12():226. PubMed ID: 25143136
[TBL] [Abstract][Full Text] [Related]
3. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
[TBL] [Abstract][Full Text] [Related]
4. Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.
Diep CH; Charles NJ; Gilks CB; Kalloger SE; Argenta PA; Lange CA
Cell Cycle; 2013 May; 12(9):1433-49. PubMed ID: 23574718
[TBL] [Abstract][Full Text] [Related]
5. Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN status.
Bashash D; Sayyadi M; Safaroghli-Azar A; Sheikh-Zeineddini N; Riyahi N; Momeny M
Int J Biochem Cell Biol; 2019 Mar; 108():7-16. PubMed ID: 30639430
[TBL] [Abstract][Full Text] [Related]
6. Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA‑374a/forkhead box O1 signaling axis.
Sun Y; Peng YB; Ye LL; Ma LX; Zou MY; Cheng ZG
Mol Med Rep; 2020 Mar; 21(3):1471-1480. PubMed ID: 32016462
[TBL] [Abstract][Full Text] [Related]
7. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
[TBL] [Abstract][Full Text] [Related]
8. Suppression of c-Myc using 10058-F4 exerts caspase-3-dependent apoptosis and intensifies the antileukemic effect of vincristine in pre-B acute lymphoblastic leukemia cells.
Sheikh-Zeineddini N; Bashash D; Safaroghli-Azar A; Riyahi N; Shabestari RM; Janzamin E; Safa M
J Cell Biochem; 2019 Aug; 120(8):14004-14016. PubMed ID: 30957273
[TBL] [Abstract][Full Text] [Related]
9. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
10. CBP-mediated FOXO-1 acetylation inhibits pancreatic tumor growth by targeting SirT.
Pramanik KC; Fofaria NM; Gupta P; Srivastava SK
Mol Cancer Ther; 2014 Mar; 13(3):687-98. PubMed ID: 24419059
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of forkhead box O3 transcription is involved in C2-ceramide induced apoptosis and autophagy in ovarian cancer cells in vitro.
Jin Z; Zheng L; Xin X; Li Y; Hua T; Wu T; Wang H
Mol Med Rep; 2014 Dec; 10(6):3099-105. PubMed ID: 25323477
[TBL] [Abstract][Full Text] [Related]
12. Anti-proliferative activity of disulfiram through regulation of the AKT-FOXO axis: A proteomic study of molecular targets.
Nasrollahzadeh A; Momeny M; Fasehee H; Yaghmaie M; Bashash D; Hassani S; Mousavi SA; Ghaffari SH
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119087. PubMed ID: 34182011
[TBL] [Abstract][Full Text] [Related]
13. Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate.
Greenshields AL; Shepherd TG; Hoskin DW
Mol Carcinog; 2017 Jan; 56(1):75-93. PubMed ID: 26878598
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1.
Wu Z; Sun H; Zeng W; He J; Mao X
PLoS One; 2012; 7(9):e45825. PubMed ID: 23029264
[TBL] [Abstract][Full Text] [Related]
15. Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells.
Lin CP; Liu JD; Chow JM; Liu CR; Liu HE
Anticancer Drugs; 2007 Feb; 18(2):161-70. PubMed ID: 17159602
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression.
Tan Y; Wang L; Du Y; Liu X; Chen Z; Weng X; Guo J; Chen H; Wang M; Wang X
Int J Oncol; 2018 Dec; 53(6):2503-2517. PubMed ID: 30272279
[TBL] [Abstract][Full Text] [Related]
17. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
Kim J; Roh M; Abdulkadir SA
BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
[TBL] [Abstract][Full Text] [Related]
18. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ
Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518
[TBL] [Abstract][Full Text] [Related]
19. FOXO transcription factor-dependent p15(INK4b) and p19(INK4d) expression.
Katayama K; Nakamura A; Sugimoto Y; Tsuruo T; Fujita N
Oncogene; 2008 Mar; 27(12):1677-86. PubMed ID: 17873901
[TBL] [Abstract][Full Text] [Related]
20. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
Li C; Liu VW; Chan DW; Yao KM; Ngan HY
Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]